2011
DOI: 10.1016/j.expneurol.2011.02.015
|View full text |Cite
|
Sign up to set email alerts
|

High frequency oscillations in the subthalamic nucleus: A neurophysiological marker of the motor state in Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

15
189
6
2

Year Published

2012
2012
2019
2019

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 172 publications
(215 citation statements)
references
References 36 publications
15
189
6
2
Order By: Relevance
“…In eight PD patients, we found a significant interaction between the phase of the β-rhythm and the amplitude of a relatively narrowband high-frequency oscillation (HFO) at >200 Hz (Fig. S4), which has previously been described (18,19). This pattern of STN-STN phase-amplitude coupling is distinct from β-phasebroadband-γ coupling in that the amplitude frequency over which coupling occurs is both high and narrowband.…”
Section: Resultsmentioning
confidence: 52%
“…In eight PD patients, we found a significant interaction between the phase of the β-rhythm and the amplitude of a relatively narrowband high-frequency oscillation (HFO) at >200 Hz (Fig. S4), which has previously been described (18,19). This pattern of STN-STN phase-amplitude coupling is distinct from β-phasebroadband-γ coupling in that the amplitude frequency over which coupling occurs is both high and narrowband.…”
Section: Resultsmentioning
confidence: 52%
“…In addition, the so-called high-frequency oscillations (HFO, >200 Hz) were observed in the basal ganglia of patients with Parkinson's disease [51][52][53]. HFO are involved in the generation of voluntary movements.…”
Section: Discussionmentioning
confidence: 99%
“…For instance, high frequency power ratios, phase amplitude coupling and beta variability have all been shown to relate to Parkinsonian state 9,10,12,17 . The method described in this paper should enable the systematic investigation of such parameters and their effect on the clinical efficacy of stimulation in addition to their side effect profile.…”
Section: Discussionmentioning
confidence: 99%
“…They are stable and robust in the long term and can be recorded from the same electrodes used for clinical DBS making them attractive targets for biomarkers 8 . In addition to beta oscillations, a range of other, more complex, potential biomarkers have been identified that have been shown to relate to severity of symptoms 2,[9][10][11][12] .…”
Section: Introductionmentioning
confidence: 99%